Status:
COMPLETED
Menorrhagia Study in Women With Treatment-resistant Menorrhagia
Lead Sponsor:
Bayer
Collaborating Sponsors:
TAP Pharmaceutical Products Inc.
Conditions:
Menorrhagia
Eligibility:
FEMALE
30-55 years
Phase:
PHASE2
Brief Summary
The aim of this study is to explore effects of the investigational product for the treatment of treatment-resistant menorrhagia without organic cause.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Patients with treatment-resistant menorrhagia scheduled for hysterectomy.
Exclusion
- Organic causes of menorrhagia
- Current hormone treatment
Key Trial Info
Start Date :
November 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2004
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT00288691
Start Date
November 1 2001
End Date
January 1 2004
Last Update
December 30 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.